| Literature DB >> 27042356 |
Maryam Javadi1, Mana Oloomi1, Saeid Bouzari1.
Abstract
Diarrheagenic and uropathogenic E. coli types are mainly characterized by the expression of distinctive bacterial virulent factors. stx1, stx2 (Shiga toxins), and cdt (cytolethal distending toxin) genes have been acquired by horizontal gene transfer. Some virulent genes such as espP (serine protease), etpD (part of secretion pathway), and katP (catalase-peroxidase), or sfpA gene (Sfp fimbriae), are on plasmids and the others like fliC (flagellin) and the fimH gene (fimbriae type-I) are located on chromosome. Genomic pathogenicity islands (PAIs) carry some virulent genes such as hly gene. To determine the existence of virulence genes in cdt clinical isolates, genes including stx1, stx2, cdt, hly, espP, katP, sfpA, etpD, fliC, and fimH were assessed by Polymerase Chain Reaction (PCR). The most prevalent isolates for etpD and katP genes were 85.7% in cdtII. katP gene was also observed 83.3% in cdtI. However, in 42.85% of cdtIII isolates, espP gene was the most detected. Moreover, hly gene was also the most prominent gene in cdtIII (71.42%). sfpA gene was observed in 66.6% of cdtV. stx1 gene was detected in 100% of cdtII, cdtIV, and cdtV types. Presence and pattern of virulence genes were considered among cdt positive isotypes and used for their clustering and profiling.Entities:
Year: 2016 PMID: 27042356 PMCID: PMC4794564 DOI: 10.1155/2016/9237127
Source DB: PubMed Journal: J Pathog ISSN: 2090-3057
Nucleotide sequence of primers for amplification of target genes.
| Target gene | Nucleotide sequence (forward/reverse) | Size (bp) | Reference |
|---|---|---|---|
|
| 5′-AGC CAA GGC CAA GGG ATT ATT A-3′ | 440-bp | [ |
|
| |||
|
| 5′-AAA CAG CAG GCA CTT GAA CG-3′ | 1830-bp | [ |
|
| |||
|
| 5′-CTT CCT GTT CTG CTG ATT CTT CTG G-3′ | 2125-bp | [ |
|
| |||
|
| 5′-CGT CAG GAG GAT GTT CAG-3′ | 1062-bp | [ |
|
| |||
|
| 5′-CCA GTC ATT AAT ACA AAC AGC C-3′ | 1600-bp | [ |
|
| |||
|
| 5′-CTT ATG GCG GCG TGT TAT CTA-3′ | 289-bp | [ |
|
| |||
|
| 5′-AGG TTC TTG GGC ATG TAT CCT-3′ | 555-bp | [ |
|
| |||
|
| 5′-CGA TGT TAC GGT TTG TTA CTG TGA CAG C-3′ | 244-bp | [ |
|
| |||
|
| 5′-GTT TTG ACC ATC TTC GTC TGA TTA TTG AG-3′ | 324-bp | [ |
|
| |||
|
| 5′-CAA TAG TCG CCC ACA GGA-3′ | 411-bp | [ |
|
| |||
|
| 5′-GAA AGT AAA TGG AAT ATA AAT GTC CG-3′ | 556-bp | [ |
|
| |||
|
| 5′-GAA AGT AAA TGG AAT ATA AAT GTC CG-3′ | 555-bp | [ |
|
| |||
|
| 5′-CCT GAT GGT TCA GGA GGC TGG TTC-3′ | 350-bp | [ |
|
| |||
|
| 5′-AGC ACC CGC AGT ATC TTT GA-3′ | 1363-bp | [ |
The occurrence of virulence-associated genes including plasmid, Pathogenicity Island, chromosomal and phage genes. (+) indicates positive PCR product and the existence of mentioned gene while (−) indicates negative PCR product.
| Strain |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | − | + | + | + | − | + | + | + | − | − | − | − | − | − |
| 2 | − | − | − | − | − | − | + | + | − | − | − | − | + | − |
| 3 | − | − | + | − | − | + | + | + | − | − | − | − | + | − |
| 4 | + | − | + | − | − | + | + | + | − | − | − | − | + | − |
| 5 | − | − | + | − | − | + | + | + | − | − | − | − | + | + |
| 6 | − | + | + | − | − | + | + | + | − | − | − | − | + | + |
| 7 | − | + | + | + | − | + | + | − | + | − | − | − | + | − |
| 8 | − | + | + | − | − | + | + | − | + | − | − | − | + | − |
| 9 | − | − | + | − | + | + | + | − | + | − | − | − | + | − |
| 10 | − | + | + | − | − | + | + | − | + | − | − | − | + | − |
| 11 | − | + | + | − | − | + | + | − | + | − | − | − | + | − |
| 12 | − | + | + | − | − | + | + | − | + | − | − | − | + | − |
| 13 | − | + | − | − | − | + | + | − | + | − | − | − | + | − |
| 14 | + | − | + | − | − | + | + | − | − | + | − | − | − | − |
| 15 | + | − | + | − | + | + | + | − | − | + | − | − | − | − |
| 16 | − | + | + | − | + | + | + | − | − | + | − | − | − | − |
| 17 | + | − | − | + | − | + | + | − | − | + | − | − | + | − |
| 18 | − | − | + | − | + | + | + | − | − | + | − | − | + | − |
| 19 | − | − | − | − | + | + | + | − | − | + | − | − | + | + |
| 20 | − | + | − | − | + | + | + | − | − | + | − | − | + | − |
| 21 | + | + | + | + | − | + | + | − | − | − | + | − | + | − |
| 22 | − | − | + | + | + | + | + | − | − | − | + | − | + | − |
| 23 | − | + | − | − | − | + | + | − | − | − | + | − | + | − |
| 24 | + | + | + | − | + | + | + | − | − | − | + | − | + | + |
| 25 | − | + | − | + | + | + | + | − | − | − | + | − | + | − |
| 26 | − | − | − | − | − | + | + | − | − | − | + | − | + | − |
| 27 | − | − | + | − | + | + | + | − | − | − | + | − | + | − |
| 28 | + | − | − | − | − | + | + | − | − | − | − | + | + | − |
| 29 | − | + | − | + | + | + | + | − | − | − | − | + | + | − |
| 30 | − | + | − | + | + | + | + | − | − | − | − | + | + | − |
The frequency of target genes in different cdt-type isolates.
|
| Target gene | ||||||
|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
| |
|
| 83.33% | 33.33% | 16.6% | 16.66% | 83.33% | 33.33% | 0% |
|
| 85.7% | 85.7% | 0% | 14.28% | 100% | 0% | 14.28% |
|
| 57.14% | 28.57% | 42.85% | 14.28% | 57.14% | 14.28% | 71.42% |
|
| 57.14% | 57.4% | 28.57% | 42.85% | 100% | 14.28% | 57.14% |
|
| 0% | 66.66% | 33.33% | 66.66% | 100% | 0% | 66.66% |
Different cdt-type strains and related genotype based on other virulent genes and profile designation based on cooccurrence of plasmid-borne genes. espP: profile A, etpD: profile B, katP: profile C, espP/katP: profileD, espP/sfpA: profile E, etpD/katP: profile F, etpD/sfpA: profile G, katP/sfpA: profile H, etpD/katP/sfpA: profile I, espP/etpD/katP: profile K, espP/etpD/katP/sfpA: profile L, and profile M: Indicates the absence of plasmid genes and presence of chromosomal genes (fimH, fliC, hly, stx1, or stx2).
| Strain |
| Genotype based on virulence-related genes | Profile designation based on plasmid-borne genes |
|---|---|---|---|
| 1 |
|
| I |
| 2 |
|
| M |
| 3 |
|
| C |
| 4 |
|
| D |
| 5 |
|
| C |
| 6 |
|
| F |
| 7 |
|
| I |
| 8 |
|
| F |
| 9 |
|
| C |
| 10 |
|
| F |
| 11 |
|
| F |
| 12 |
|
| F |
| 13 |
|
| B |
| 14 |
|
| D |
| 15 |
|
| D |
| 16 |
|
| F |
| 17 |
|
| E |
| 18 |
|
| C |
| 19 |
|
| M |
| 20 |
|
| B |
| 21 |
|
| L |
| 22 |
|
| H |
| 23 |
|
| B |
| 24 |
|
| K |
| 25 |
|
| G |
| 26 |
|
| M |
| 27 |
|
| C |
| 28 |
|
| A |
| 29 |
|
| G |
| 30 |
|
| G |
The frequency of different cdt-types based on virulent plasmid-borne genes in isolates totally.
| Profile | Target gene | ||||
|---|---|---|---|---|---|
|
|
|
|
|
| |
| A | 0% | 0% | 0% | 0% | 100% |
| B | 0% | 33.33% | 33.33% | 33.33% | 0% |
| C | 40% | 20% | 20% | 20% | 0% |
| D | 33.33% | 0% | 66.67% | 0% | 0% |
| E | 0% | 0% | 100% | 0% | 0% |
| F | 16.67% | 66.67% | 16.67% | 0% | 0% |
| G | 0% | 0% | 0% | 33.33% | 66.67% |
| H | 0% | 0% | 0% | 100% | 0% |
| I | 50% | 50% | 0% | 0% | 0% |
| K | 0% | 0% | 0% | 100% | 0% |
| L | 0% | 0% | 0% | 100% | 0% |
| M | 33.33% | 0% | 33.33% | 33.33% | 0% |
Figure 1Dendrogram using average linkage between groups: This figure illustrates hierarchical clustering analyses between 30 examined clinical isolates which are clustered based on virulence-associated factors including virulent plasmid, phage, chromosomal, and pathogenicity island genes. At the end of each branch the numbers indicate strains, as moving to the right relative distance becomes more apparent. Distances are more distinct by using a 0 to 25 scale along the top of the chart. Depicted table which is in front of the tree illustrates the comparative patterns of cooccurrence and presence of virulent genes in different strains (light gray scale shows gene loss and different dark gray scales show different virulent genes genesis). Defined pattern can be observed for each cdt-type isolates based on other virulent genes.